D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
iRobot
IRBT
$107M
| $8.18M | 0.01% |
128,989
+44,718
| +53% | +$2.84M |
|
|
TIGR
1127
UP Fintech Holding
TIGR
$2B
| $8.14M | 0.01% |
1,660,525
+1,127,779
| +212% | +$5.53M |
|
|
SWAV
1128
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.14M | 0.01% |
39,242
-63,050
| -62% | -$13.1M |
|
1129
Calidi Biotherapeutics
CLDI
$8.67M
| $8.11M | 0.01% |
6,831
+33
| +0.5% | +$39.2K |
|
|
TZPS
1130
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
| $8.1M | 0.01% |
825,709
+508,237
| +160% | +$4.99M |
|
|
FTEV
1131
DELISTED
FinTech Evolution Acquisition Group
FTEV
| $8.1M | 0.01% |
826,302
-263,408
| -24% | -$2.58M |
|
1132
Unisys
UIS
$282M
| $8.09M | 0.01% |
374,456
-92,181
| -20% | -$1.99M |
|
1133
Home BancShares
HOMB
$5.89B
| $8.08M | 0.01% |
357,607
+174,978
| +96% | +$3.95M |
|
1134
AAR Corp
AIR
$2.67B
| $8.07M | 0.01% |
166,548
-162,029
| -49% | -$7.85M |
|
1135
Newmark Group
NMRK
$3.41B
| $8.05M | 0.01% |
505,803
+386,761
| +325% | +$6.16M |
|
1136
Quanta Services
PWR
$57B
| $8.05M | 0.01% |
61,143
-167,722
| -73% | -$22.1M |
|
1137
Carpenter Technology
CRS
$12B
| $8.04M | 0.01% |
191,425
+45,701
| +31% | +$1.92M |
|
|
VXRT
1138
DELISTED
Vaxart
VXRT
| $8.03M | 0.01% |
1,592,641
-534,283
| -25% | -$2.69M |
|
|
VMCAU
1139
DELISTED
Valuence Merger Corp. I Unit
VMCAU
| $8.02M | 0.01% |
+800,000
| New | +$8.02M |
|
|
OACB
1140
DELISTED
Oaktree Acquisition Corp. II
OACB
| $8.01M | 0.01% |
804,929
-87,628
| -10% | -$872K |
|
|
THAC
1141
DELISTED
Thrive Acquisition Corporation Class A ordinary shares
THAC
| $8M | 0.01% |
800,406
+178,724
| +29% | +$1.79M |
|
|
VTIQ
1142
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
| $8M | 0.01% |
812,637
| – | – |
|
1143
Modine Manufacturing
MOD
$7.86B
| $7.97M | 0.01% |
884,097
+56,677
| +7% | +$511K |
|
|
MIT
1144
DELISTED
Mason Industrial Technology, Inc.
MIT
| $7.96M | 0.01% |
814,923
+301,346
| +59% | +$2.94M |
|
1145
Colliers International
CIGI
$8.48B
| $7.96M | 0.01% |
61,100
-4,900
| -7% | -$638K |
|
1146
Itaú Unibanco
ITUB
$75B
| $7.94M | 0.01% |
1,529,460
+1,389,908
| +996% | +$7.21M |
|
1147
Cytek Biosciences
CTKB
$501M
| $7.91M | 0.01% |
734,056
+718,217
| +4,534% | +$7.74M |
|
|
CMCA
1148
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
| $7.91M | 0.01% |
+796,010
| New | +$7.91M |
|
1149
Chemed
CHE
$6.5B
| $7.91M | 0.01% |
15,616
+7,277
| +87% | +$3.69M |
|
|
GAPA
1150
DELISTED
G&P Acquisition Corp.
GAPA
| $7.89M | 0.01% |
794,908
+61,000
| +8% | +$605K |
|